RxDoctor Payments Data

Raymond Kim

Denver, CONPI 1861440133

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $3,748,412 of the $4,237,364 with a category attached, or 88.5%. Encore Medical, LP accounts for 99.6% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $1,065,629, 2.8 times the $380,448 reported in 2019.

$4,234,877in general payments, 2019–2025

Across 529 payments — averaging $8005.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Encore Medical, LP$4.2M
  • Convatec Inc.$12K
  • Stryker$1K
  • Insight Medical Systems, Inc.$800
  • Zimmer Biomet$559
  • Smith+Nephew$512
  • plus $2K from 13 others

What the payments were for

  • Royalty or licence$3,748,41288%
  • Consulting fees$430,87710%
  • Travel & lodging$48,0291%
  • Food & beverage$10,0450%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →